Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Teufel

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|September 14, 2023
Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1Tânia F Custódio, Maxime Killer, Dingquan Yu, et al.
Journal of Medicinal Chemistry|March 24, 2020
Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic PayloadsGemma E Mudd, Amy Brown, Liuhong Chen, et al.
Journal of Medicinal Chemistry|March 9, 2018
Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular EdemaDaniel P Teufel, Gavin Bennett, Helen Harrison, et al.
Cancer Research|January 5, 2019
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|September 14, 2023
Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1Tânia F Custódio, Maxime Killer, Dingquan Yu, et al.
Journal of Medicinal Chemistry|March 24, 2020
Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic PayloadsGemma E Mudd, Amy Brown, Liuhong Chen, et al.
Journal of Medicinal Chemistry|March 9, 2018
Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular EdemaDaniel P Teufel, Gavin Bennett, Helen Harrison, et al.
Cancer Research|January 5, 2019
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.
Pageof 4